|
Name |
Dihydroprehelminthosporol
|
Molecular Formula | C15H26O2 | |
IUPAC Name* |
[(1R,4R,5R,6R,8S)-8-(hydroxymethyl)-1-methyl-7-methylidene-4-propan-2-yl-6-bicyclo[3.2.1]octanyl]methanol
|
|
SMILES |
CC(C)[C@H]1CC[C@@]2([C@H]([C@H]1[C@H](C2=C)CO)CO)C
|
|
InChI |
InChI=1S/C15H26O2/c1-9(2)11-5-6-15(4)10(3)12(7-16)14(11)13(15)8-17/h9,11-14,16-17H,3,5-8H2,1-2,4H3/t11-,12+,13+,14-,15+/m1/s1
|
|
InChIKey |
KFSUHYMYSGYWGI-FQKPHLNHSA-N
|
|
Synonyms |
Dihydroprehelminthosporol; 118069-95-7; [(1R,4R,5R,6R,8S)-8-(hydroxymethyl)-1-methyl-7-methylidene-4-propan-2-yl-6-bicyclo[3.2.1]octanyl]methanol
|
|
CAS | NA | |
PubChem CID | 134715067 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 238.37 | ALogp: | 2.7 |
HBD: | 2 | HBA: | 2 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 40.5 | Aromatic Rings: | 2 |
Heavy Atoms: | 17 | QED Weighted: | 0.741 |
Caco-2 Permeability: | -4.423 | MDCK Permeability: | 0.00001040 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.003 |
Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.009 |
30% Bioavailability (F30%): | 0.008 |
Blood-Brain-Barrier Penetration (BBB): | 0.97 | Plasma Protein Binding (PPB): | 80.50% |
Volume Distribution (VD): | 1.016 | Fu: | 20.63% |
CYP1A2-inhibitor: | 0.172 | CYP1A2-substrate: | 0.271 |
CYP2C19-inhibitor: | 0.013 | CYP2C19-substrate: | 0.865 |
CYP2C9-inhibitor: | 0.022 | CYP2C9-substrate: | 0.071 |
CYP2D6-inhibitor: | 0.003 | CYP2D6-substrate: | 0.117 |
CYP3A4-inhibitor: | 0.061 | CYP3A4-substrate: | 0.561 |
Clearance (CL): | 8.866 | Half-life (T1/2): | 0.652 |
hERG Blockers: | 0.041 | Human Hepatotoxicity (H-HT): | 0.222 |
Drug-inuced Liver Injury (DILI): | 0.099 | AMES Toxicity: | 0.01 |
Rat Oral Acute Toxicity: | 0.187 | Maximum Recommended Daily Dose: | 0.016 |
Skin Sensitization: | 0.174 | Carcinogencity: | 0.074 |
Eye Corrosion: | 0.444 | Eye Irritation: | 0.886 |
Respiratory Toxicity: | 0.449 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000976 | 0.492 | D04CSZ | 0.276 | ||||
ENC001878 | 0.468 | D08SVH | 0.221 | ||||
ENC002278 | 0.460 | D04VIS | 0.215 | ||||
ENC001293 | 0.459 | D05BTM | 0.210 | ||||
ENC001779 | 0.452 | D0T2PL | 0.210 | ||||
ENC004835 | 0.444 | D0Y7LD | 0.208 | ||||
ENC002277 | 0.444 | D0K5WS | 0.206 | ||||
ENC003649 | 0.431 | D02VPX | 0.202 | ||||
ENC005456 | 0.424 | D02ZGI | 0.198 | ||||
ENC002553 | 0.410 | D0G5CF | 0.198 |